Effect of Fenofibrate and Rosuvastatin on Sexual Dysfunction in Hyperlipidemic Patients. A Randomized Trial.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Nov 2017
At a glance
- Drugs Fenofibrate (Primary) ; Rosuvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 17 Nov 2015 Planned End Date changed from 1 Nov 2009 to 1 Apr 2016 as reported by ClinicalTrials.gov.
- 22 Jun 2009 New trial record